Chongqing Jiheng Pharmaceutical Co., Ltd. (SHE:002742)

SHE:002742 Revenue

Chongqing Jiheng Pharmaceutical had revenue of 93.67M CNY in the quarter ending September 30, 2026, a decrease of -62.67%. This brings the company's total for the last twelve months to 496.97M, down -47.51% year-over-year. In the year 2025, Chongqing Jiheng Pharmaceutical had annual revenue of 899.85M, down -24.74%. That makes Chongqing Jiheng Pharmaceutical the 24,987th largest company in the world by revenue and 4,462nd in China.

• Revenue (ttm): 496.97M
• Revenue Growth: -47.51%
• P/S Ratio: 4.85
• Revenue / Employee: 507.63K
• Employees: 979
• Market Cap: 2.41B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Medicine 529.82M 58.9%
• Building Materials Chemical Industry 349.94M 38.9%
• Unallocated Other Operations 20.09M 2.2%

By Geography

Chart

• China 698.63M 74.9%
• Overseas 234.17M 25.1%

Fiscal year ended Dec 31, 2025 See the full SHE:002742 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	899.85M	-295.87M	-24.74%
Dec 31, 2024	1.20B	-834.52M	-41.10%
Dec 31, 2023	2.03B	-46.79M	-2.25%
Jan 1, 2023	2.08B	-412.12M	-16.56%
Jan 1, 2022	2.49B	-60.36M	-2.37%

Data Source: S&P Global Market Intelligence Last updated: Oct 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error